Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Diseases
100%
Neoplasm
98%
Melanoma
92%
Malignant Neoplasm
64%
Breast Cancer
54%
Overall Survival
52%
Tumor
52%
Chemotherapy
51%
Recurrent Disease
44%
Metastatic Carcinoma
42%
Cancer
36%
Retroperitoneal Lymph Node Dissection
35%
Lymph Node
31%
Radiation Therapy
31%
Glioblastoma
30%
Aneurysm
30%
Surgeon
29%
Clinical Trial
29%
Metastatic Melanoma
29%
Oncology
28%
Cervical Cancer
28%
Sentinel Lymph Node
27%
Gynecological Oncology
27%
Sentinel Node
26%
Progression Free Survival
24%
Apoplexy
23%
Magnetic Resonance Imaging
23%
Colorectal Carcinoma
22%
Embolization
22%
Lymph Duct
22%
Biopsy Technique
20%
Surgery
19%
Cisplatin
19%
Ovarian Cancer
19%
Brain Metastasis
19%
Morbidity
18%
Biological Marker
18%
Immunotherapy
17%
Drug Megadose
17%
Bevacizumab
17%
Adverse Event
16%
Quality of Life
16%
Primary Tumor
16%
Prostate Cancer
16%
Melanoma Skin Cancer
16%
Colon Carcinoma
15%
Arm
15%
Surgical Technique
14%
Cystectomy
14%
Neck
14%
Krukenberg Tumor
13%
Genetics
13%
Brain Ischemia
13%
Interleukin 2
13%
Intracranial Tumor
13%
COVID-19
13%
Disease Free Survival
13%
Skull Base
13%
Mastectomy
13%
Pediatrics
13%
Transsphenoidal Surgery
13%
Phase II Trials
12%
Health Care Cost
12%
Survival Rate
12%
Ganglioglioma
11%
Median Follow Up
11%
Pelvis
11%
Meningioma
11%
Symptomatic Treatment
11%
Hazard Ratio
11%
Multivariate Analysis
11%
Cerebral Hemorrhage
11%
Adolescence
11%
Adjuvant Therapy
11%
Odds Ratio
10%
Prognostic Factor
10%
Computer Assisted Tomography
10%
Placebo
10%
Robot-Assisted Prostatectomy
9%
Clear Cell Renal Cell Carcinoma
9%
Adenocarcinoma
9%
Infection
9%
Liver Metastasis
9%
Angiography
9%
Carcinoma
9%
Intracranial Aneurysm
9%
Platinum
9%
Systematic Review
9%
Tumor Cell
9%
Endovascular Coiling
9%
Micrometastasis
9%
Squamous Cell Carcinoma
9%
Craniotomy
9%
Arteriovenous Malformation
8%
High Dose Chemotherapy
8%
Histology
8%
Germinoma
8%
Thyroid Cancer
8%
In Vitro
8%
Temozolomide
8%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
42%
Diseases
39%
Melanoma
33%
Neoplasm
32%
Chemotherapy Regimens
31%
Breast Cancer
25%
Overall Survival
22%
Clinical Trial
22%
Uterine Cervix Cancer
20%
Bevacizumab
19%
Glioblastoma
19%
Progression Free Survival
19%
Phase II Trials
17%
Recurrent Disease
15%
Cisplatin
13%
Solid Malignant Neoplasm
13%
Adverse Event
12%
Interleukin 2
12%
Ovary Cancer
11%
Prostate Cancer
10%
Brain Metastasis
10%
Biological Marker
10%
Metastatic Melanoma
9%
Immunotherapy
8%
Phase I Trials
8%
Pharmacokinetics
8%
Carboplatin
8%
Placebo
8%
Fluorouracil
8%
Paclitaxel
8%
Cytokine
7%
Colorectal Carcinoma
7%
Tumor Growth
7%
Temozolomide
7%
Castration Resistant Prostate Cancer
6%
Ovary Carcinoma
6%
Platinum
6%
Ipilimumab
6%
Renal Cell Carcinoma
6%
Vasculotropin
5%
Gemcitabine
5%
Interferon
5%
Peptide
5%
Multiple Sclerosis
5%
Doxorubicin
5%
Cyclophosphamide
5%
Maximum Tolerated Dose
5%